Functional gastrointestinal (GI) symptoms are common in the general population with a reported prevalence of 25-40%. These symptoms account for up to 40% of GI office consultations. Often, patients presenting with functional GI symptoms have evidence of a diffuse GI motility disorder.1 Upper and lower gut symptoms often overlap, therefore, localizing transit abnormalities to a specific GI region is important in diagnostic evaluation and should be done early in the process to guide appropriate therapy.2
SmartPill motility monitoring assists in localizing transit abnormalities to a specific GI region by collecting data from the entire GI tract. As the SmartPill capsule travels through the patient’s GI tract, it measures pressure, pH and temperature to provide you with valuable diagnostic information including gastric emptying and total GI transit times.
SmartPill motility monitoring can be performed in the clinic or physician’s office and eliminates the dependency on radiological tests. Other features of SmartPill include:
- The only motility test that provides a complete transit profile of the GI tract
- Increased sensitivity compared to Gastric Emptying Scintigraphy (GES) and Radio Opaque Markers (ROM)
- Ability to localize disease to specific regions of the GI tract in the presence of overlapping motility symptoms
- Standardized motility testing process with benchmarked results
1Bonapace et al. Whole Gut Transit Scintigraphy in the Clinical Evaluation of Patients with Upper and Lower Gastrointestinal Symptoms. Am J Gastroenterol 2000; 95:2838-2847.
2Lin et al. Measurement of Gastrointestinal Transit. Digestive Diseases and Sciences 2005; 50:989.